*Patents for the M3-pinhole™ and Tera-Tomo™ technologies are pending.

About Mediso Ltd.:
Mediso is one of the World's largest suppliers of various medical diagnostic and research purpose, single and multimodality imaging devices. The company was founded in 1990 by experts in the largest research and manufacturing company in Europe which has been engaged of nuclear equipment development and production since 1960.
Currently Mediso offers 4 imaging modalities - SPECT, PET, CT, MRI - for professionals working in laboratories and nuclear medicine departments.
Mediso products are sold worldwide directly and through a network of distributors. There are more than 1000 imaging systems operating in more than 85 countries around the world.

Mediso offers two multi-modality lines:

The current flagship of the preclinical line is the first member of the nanoScan® product family, the fully integrated in-line nanoScan® PET/MRI imager. With the introduction of two new members in 2012, the SPECT/MRI and the SPECT/CT, the nanoScan® family has quickly become a powerful, versatile four modality imaging platform.

Dominant member of the clinical line is the AnyScan® SPECT-CT-PET system, which is currently the only triple modality human diagnostic equipment and offers the most advanced SPECT detector technology, beside a full PET ring and a diagnostic CT.

For more information, please visit the Mediso web site at www.mediso.com.

For further information about the nanoScan® product family and Mediso, please contact:

Mediso Medical Imaging Systems
H-1022 Budapest, Alsótörökvész 14.
Phone: +36-1-399-3030
Fax: +36-1-399-3040
E-mail: sales@mediso.hu

Press contact:
Dr. Gábor Németh, Program Director, Preclinical Imaging
E-mail: gabor.nemeth@mediso.hu
Mobile: +36 (30) 9000-933

Back to HCB News

More HCB News